Rymti (etanercept)

pCPA File Number: 22082

Negotiation Status:

Active Negotiation

Indication(s):

ankylosing spondylitis, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis and polyarticular juvenile idiopathic arthritis

Sponsor/Manufacturer:

Lupin Pharma Canada Ltd.

CADTH Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2023-02-22

Negotiation Process Concluded:

Not Applicable